📢 SeaBeLife Biotech will be attending the 8th annual LSX Inv€$tival Showcase
Morgane Rousselot, our founder and CEO, and @Jean-Pierre Kinet, a prominent member of our strategic committee and chairman of iXLife Capital will be present for the event.
🚀 We are currently developing patented molecules designed to stop regulated cell death in order to protect or regenerate organs affected by severe pathologies such as acute liver disease including paracetamol poisoning, age-related macular degeneration (AMD), Parkinson’s disease and other neurodegenerative diseases (including Alzheimer’s).
💶 This comes following our recent €1,2 million funding round to further advance the development of our pipeline of innovative and unique drugs.
👥 This is an opportunity for investors to come and meet our leadership and discover more about how our team is developing its range of new drugs.
We hope to be a part of insightful discussions and explore future collaborations
📅 Join us in London on Monday 13th November with our host @LSX – partnering for Life Science executives :